Market Closed -
Nasdaq
03:39:45 2024-06-04 pm EDT
|
5-day change
|
1st Jan Change
|
1.33
USD
|
-6.99%
|
|
-9.52%
|
+95.59%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
38.91
|
26.6
|
46.74
|
10.04
|
6.392
|
12.5
|
-
|
-
|
Enterprise Value (EV)
1 |
38.91
|
26.6
|
46.74
|
10.04
|
6.392
|
12.5
|
12.5
|
12.5
|
P/E ratio
|
-2.22
x
|
-1.06
x
|
-2.11
x
|
-0.27
x
|
-0.31
x
|
-0.64
x
|
-0.81
x
|
-0.76
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
77.8
x
|
53.2
x
|
93.5
x
|
20.1
x
|
-
|
-
|
-
|
-
|
EV / Revenue
|
77.8
x
|
53.2
x
|
93.5
x
|
20.1
x
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-0.54
x
|
-0.36
x
|
-0.28
x
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-184%
|
-280%
|
-360%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
1,517
|
2,495
|
5,771
|
7,434
|
9,399
|
9,401
|
-
|
-
|
Reference price
2 |
25.65
|
10.66
|
8.100
|
1.350
|
0.6800
|
1.330
|
1.330
|
1.330
|
Announcement Date
|
3/25/20
|
3/19/21
|
3/31/22
|
3/30/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
0.5
|
0.5
|
0.5
|
0.5
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-20.56
|
-18.49
|
-21.01
|
-24.92
|
-21.03
|
-21.34
|
-25.59
|
-39.1
|
Operating Margin
|
-4,113%
|
-3,697.2%
|
-4,201.4%
|
-4,984.4%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-18.67
|
-23.33
|
-22.15
|
-37.46
|
-20.8
|
-21.7
|
-25.56
|
-38.7
|
Net income
1 |
-16.85
|
-21.48
|
-20.77
|
-35.9
|
-19.52
|
-21.21
|
-25.56
|
-38.7
|
Net margin
|
-3,370.4%
|
-4,296.8%
|
-4,153.8%
|
-7,179.6%
|
-
|
-
|
-
|
-
|
EPS
2 |
-11.55
|
-10.05
|
-3.830
|
-5.030
|
-2.160
|
-2.093
|
-1.640
|
-1.755
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-
|
-23
|
-35
|
-45
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/25/20
|
3/19/21
|
3/31/22
|
3/30/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
0.125
|
0.125
|
0.125
|
0.125
|
0.125
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-5.491
|
-5.842
|
-5.978
|
-6.174
|
-6.927
|
-5.684
|
-5.474
|
-3.904
|
-5.968
|
-5.011
|
-5.27
|
-5.3
|
-5.765
|
Operating Margin
|
-4,392.54%
|
-4,673.6%
|
-4,782.4%
|
-4,939.2%
|
-5,541.75%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-5.605
|
-10.47
|
-6.043
|
-6.148
|
-14.8
|
-5.591
|
-5.559
|
-3.477
|
-6.168
|
-4.93
|
-5.336
|
-5.2
|
-5.765
|
Net income
1 |
-4.221
|
-10.47
|
-6.043
|
-6.148
|
-13.23
|
-5.591
|
-5.559
|
-3.477
|
-4.888
|
-4.93
|
-5.336
|
-5.2
|
-5.765
|
Net margin
|
-3,376.85%
|
-8,379.2%
|
-4,834.4%
|
-4,918.4%
|
-10,585.95%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-3.620
|
-1.820
|
-0.8700
|
-0.8700
|
-1.610
|
-0.6800
|
-0.6100
|
-0.3700
|
-0.5200
|
-0.5200
|
-0.5500
|
-0.5333
|
-0.4900
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/31/22
|
5/16/22
|
8/15/22
|
11/14/22
|
3/30/23
|
5/11/23
|
8/10/23
|
11/14/23
|
3/28/24
|
5/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-
|
-23
|
-35
|
-45
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
-
|
-
|
-
|
-
|
-
|
1
|
1
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/25/20
|
3/19/21
|
3/31/22
|
3/30/23
|
3/28/24
|
-
|
-
|
-
|
Last Close Price
1.33
USD Average target price
10
USD Spread / Average Target +651.88% Consensus |
1st Jan change
|
Capi.
|
---|
| +95.59% | 12.5M | | +16.73% | 123B | | +13.04% | 107B | | -5.80% | 24.01B | | +1.69% | 22.59B | | -10.09% | 18.16B | | -40.52% | 16.84B | | -14.00% | 16.23B | | +1.18% | 13.43B | | +24.18% | 11.32B |
Bio Therapeutic Drugs
|